BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30307891)

  • 1. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
    Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
    Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases.
    Yin JB; Wang X; Zhang X; Liu L; Wang RT
    Sci Rep; 2018 Apr; 8(1):6014. PubMed ID: 29662100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
    Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
    BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
    Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
    Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
    Barth DA; Riedl JM; Posch F; Smolle MA; Kasparek AK; Niedrist T; Szkandera J; Stöger H; Pichler M; Stotz M; Gerger A
    Clin Transl Oncol; 2019 Aug; 21(8):1034-1043. PubMed ID: 30671731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.
    Xiao Y; Yang H; Lu J; Li D; Xu C; Risch HA
    BMC Cancer; 2019 Oct; 19(1):1020. PubMed ID: 31664937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
    Li N; Lv XH; Wang X; Wang RT; Huang YX
    Breast Cancer; 2019 Nov; 26(6):712-718. PubMed ID: 31087273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
    Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
    Lanki M; Seppänen H; Mustonen H; Hagström J; Haglund C
    PLoS One; 2019; 14(7):e0219245. PubMed ID: 31314777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent association of mean platelet volume with overall survival in multiple myeloma.
    Zhuang Q; Xiang L; Xu H; Fang F; Xing C; Liang B; Yu K; Feng J
    Oncotarget; 2016 Sep; 7(38):62640-62646. PubMed ID: 27566590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
    Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
    Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study.
    Jank BJ; Haas M; Dunkler D; Campion NJ; Brkic FF; Heiduschka G; Kadletz L
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31684119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
    Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.